Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fuzheng Guben Granules is a Traditional Chinese Medicine (TCM) product developed and manufactured by Shanxi Zhendong Pharmacy. It is formulated based on the TCM principle of "strengthening the body's resistance and consolidating the constitution" (Fuzheng Guben), which is primarily used to treat deficiencies in "Qi" and "Yin." The preparation consists of a complex blend of herbal extracts, including *Codonopsis pilosula*, *Astragalus membranaceus*, *Lycium barbarum*, and *Rehmannia glutinosa*, which are traditionally recognized for their ability to tonify the spleen and kidneys. Clinically, it is indicated for the relief of symptoms such as fatigue, dizziness, and weakness, and it is frequently utilized as an adjuvant therapy to support immune function and metabolic resilience in patients recovering from chronic illness or undergoing immunosuppressive treatments.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fuzheng Guben Granules.